BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Biovista

Biovista logo

Founded
1999
Geography
United States of America based

Biovista delivers custom drug repositioning, drug de-risking and clinical hold solutions for the Biopharma Industry. Biovista also develops powerful platform technologies for Life science and Biotechnology companies. Biovista has an ongoing R&D program to develop new and improve existing products and services.


rare diseases

Technologies

AI Companies (Drug Discovery)  

R&D Platform

Drug repositioning specialist Biovista Inc. has tapped Hewlett Packard Enterprise Co. (HPE) to add greater computing power to Project Prodigy, a personalized medicine platform that leverages artificial intelligence (AI) to help doctors identify novel drugs for hard-to-treat patients.This proprietary platform, called COSS™ (Clinical Outcomes Search Space), supports Biovista scientists in uncovering non-obvious correlations between drugs, molecular targets, pathways, adverse events and diseases and constructing evidence-based biological plausibility rationale on a systematic and highly predictable basis.


COSS

Read more

Pipelines

Combo Therapy
Clinical  |  Visit website

None

BVA-201
Preclinical  |  Visit website

Biovista’s repositioned drug candidate BVA201 targeting Multiple Sclerosis (MS) is ready for Proof of Concept (PoC) studies in man.

Products

 

Services

No services posted yet